Cardiovascular-disorders
The LANCET: Diabetes &
Endocrinology: Published on July, 2022Diabetes is a major cause of death,
cardiovascular complications, and health-care burden worldwide.People with type 2 diabetes who
have high blood pressure are at an increased risk of morbidity and death from
major cardiovascular events.However, there are inadequate
randomised contro...
The New England Journal of Medicine (NEJM): Published
on April, 2022Antihypertensive treatment during
pregnancy reduces the frequency of severe hypertension (blood pressure,
≥160/110 mm Hg) but has not been shown to improve maternal, fetal, or neonatal
outcomes and has been associated with an increased risk of
small-for-gestational-age birth w...
The 2021 WHO hypertension guideline
aims to provide the most current and relevant evidence based global public
health guidance on the initiation of treatment (with pharmacological agents)
for hypertension in adults. The recommendations target adult,
non-pregnant patients who were appropriately diagnosed with hypertension and counseled
about li...
AHA Journals: Hypertension: Published on May, 2022Diabetes is a strong risk factor
for end-stage renal disease (ESRD). Hypertension also plays a crucial role
in the development and progression of kidney failure. Blood pressure (BP)
rises with declining kidney function which in turn aggravates hypertension. Moreover, as chronic kidney disease
(C...
ACP Journals: Annals of Internal Medicine: Published on
November, 2022Current guidelines recommend using
direct oral anticoagulants (DOACs) over warfarin in patients with atrial
fibrillation (AF), but head-to-head trial data do not exist to guide the choice
of DOAC.The aim
of the study is to do a large-scale comparison between all DOACs
(apix...
The Lancet: Published on October, 2022Hypertension, or high blood
pressure, is a key risk factor for cardiovascular disease worldwide. Previous clinical trials supporting
the cardiovascular benefits of antihypertensive therapy primarily use
conventional morning dosing. Additionally, cardiovascular events
are temporally associated with the morni...
European Heart Journal: September, 2022Cardiovascular (CV) disease (CVD) is the leading cause of
morbidity and mortality worldwide, despite continuous improvement of medical
treatment, diagnosis, and risk factor control. It has been clearly
demonstrated that statin therapy confers significant mortality and morbidity
benefits in both the primary...
Journal of the American
Heart Association (AHA): Published on November, 2022Sleep, alongside diet and physical activity (PA), is one of
the 3 pillars of health, but unlike other health behaviors, healthy sleep is
not included in the American College of Cardiology/American Heart Association
(AHA) cardiovascular disease (CVD) prevention guideline...
Journal of the American College of Cardiology: Published on December,
2022Healthy dietary patterns are rich
in micronutrients, but their influence on cardiovascular disease (CVD) risks
has not been systematically quantified.The goal of this study was to
provide a comprehensive and most up-to-date evidence-based map that
systematically quantifi...
AHA Journal: Circulation: Published on February,
2023Low-density lipoprotein cholesterol
(LDL-C) level is a well-established risk factor for atherosclerotic
cardiovascular disease. However, the optimal achieved LDL-C level with regard
to efficacy and safety in the long term remains unknown.TAKE-HOME MESSAGEThis study assessed the
relationship...
The Lancet:
The traditional Mediterranean diet consisted of a high proportion of
fruits, vegetables, nuts, legumes, and cereals, a moderate intake of fish and
poultry as the main protein source and olive oil as the main fat source. A low
intake of dairy products, red meat, processed meats, and sweets.
Current recommendation for patient...
JAMA Cardiology: Published on June, 2022
TAKE-HOME MESSAGE
Question: Is
starting cardiac rehabilitation exercise training 2 weeks after sternotomy as
effective and safe as starting 6 weeks after sternotomy?
Findings: In
this assessor-blind, noninferiority, randomized clinical trial of 158 cardiac
surgery patients, starting cardiac...
